Skip to main content

Table 1 Demographic data of patients

From: Clinical effectiveness of the sequential 4-channel NMES compared with that of the conventional 2-channel NMES for the treatment of dysphagia in a prospective double-blind randomized controlled study

  

4ch NMES

(n = 12)

2ch NMES

(n = 11)

P-value

Male

 

7 (58.3%)

5 (45.5%)

0.795

Hypertension

 

2 (16.7%)

6 (54.5%)

0.057

DM

 

0 (0%)

2 (18.2%)

0.122

Prior CVA

 

9 (75%)

6 (54.5%)

0.304

Smoking Hx

 

1 (8.3%)

2 (18.2%)

0.484

Cervical op

 

0 (0.0%)

0 (0.0%)

1.000

Stroke:ICH

 

9:3

4:7

0.062

Disease duration (day)

 

49.2 ± 109.1

32.6 ± 24.8

0.487

MMSE-K

 

16.8 ± 10.3

11.9 ± 8.7

0.347

VDS

Oral

19.3 ± 4.5

14.4 ± 6.8

0.059

Pharyngeal

44.3 ± 12.7

36.9 ± 10.7

0.104

Total

63.7 ± 15.1

51.4 ± 15.7

0.051

PAS

 

5.7 ± 2.2

4.4 ± 2.7

0.316

FOIS

 

1.8 ± 1.5

3.4 ± 1.6

0.032

NMES treatment duration (min)

411.8 ± 40.5

409.2 ± 67.6

0.786

NMES Amplitude (mA)

Channel 1

7.1 ± 2.9

9.4 ± 1.8

0.079

 

Channel 2

7.3 ± 3.3

9.4 ± 1.8

0.095

 

Channel 3

7.2 ± 3.0

  
 

Channel 4

4.9 ± 1.9

  

Stroke territory

 

(n = 9)

(n = 5)

 

ACA territory

 

0 0.0%)

0 (0.0%)

 

MCA territory

 

4 (44.4%)

4 (80%)

 

PCA territory

 

0 (0.0%)

0 (0.0%)

 

Brainstem lesion

 

5 (55.6%)

1 (20%)

 
  1. ACA anterior cerebral artery, MCA middle cerebral artery, PCA posterior cerebral artery
  2. *P < 0.05
Back to article page

Journal of NeuroEngineering and Rehabilitation

ISSN: 1743-0003

Contact us